NIH study for SPMS underway on experimental drug Rituximab
NIH study for SPMS underway on experimental drug Rituximab
There are currently no effective treatments for people with secondary-progressive MS who do not experience relapses or who do not have “active” lesions on MRI, however researchers at the National Institutes of Health in Bethesda, Maryland are evaluating the safety and effectiveness of Rituximab (trade names Rituxan and MabThera) – a new experimental drug for treating MS. In this study, Rituximab be delivered intravenously and directly into the cerebrospinal fluid by lumbar puncture of about 80 people with secondary-progressive Multiple Sclerosis. The study is funded by the National Institute of Neurological Disorders and Stroke...... Read More - http://www.ms-uk.org/rituxan
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1163 Views
-
Last post by NHE
-
- 0 Replies
- 11740 Views
-
Last post by NHE
-
- 0 Replies
- 4412 Views
-
Last post by NHE
-
- 0 Replies
- 2097 Views
-
Last post by frodo
-
- 0 Replies
- 2016 Views
-
Last post by NHE
-
- 1 Replies
- 1563 Views
-
Last post by ElliotB
-
- 0 Replies
- 492 Views
-
Last post by NHE
-
- 0 Replies
- 1668 Views
-
Last post by NHE
-
- 1 Replies
- 3138 Views
-
Last post by Tif